A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis2018-01-17T17:06:15-05:00
A randomized, double-blind, dosecomparison study of weekly interferon B-1a in relapsing MS A randomized, double-blind, dosecomparison study of weekly interferon B-1a in relapsing MS2018-01-17T17:03:31-05:00
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes2018-01-17T17:03:07-05:00
